HomeLatest ThreadsGreatest ThreadsForums & GroupsMy SubscriptionsMy Posts
DU Home » Latest Threads » Forums & Groups » Main » Latest Breaking News (Forum) » EXCLUSIVE-OxyContin maker...

Tue Jan 28, 2020, 07:23 PM

EXCLUSIVE-OxyContin maker Purdue is 'Pharma Co X' in U.S. opioid kickback probe -sources

Source: Reuters

NEW YORK, Jan 28 (Reuters) - OxyContin maker Purdue Pharma LP is the unnamed company that surfaced in criminal charging documents filed earlier this week in a probe of illegal kickbacks from drugmakers, according to people familiar with the matter.

Purdue Pharma, which faces U.S. Justice Department probes and sprawling litigation over allegations that it played a central role in the deadly U.S. opioid epidemic, faces new scrutiny in connection with a case Vermont federal prosecutors unveiled on Monday against a San Francisco electronic health records vendor.

The vendor allegedly received a roughly $1 million illegal kickback from an opioid company identified in the documents as "Pharma Co. X." The unnamed company is Purdue Pharma, the people familiar with the matter said. Purdue was not criminally charged in the case or accused of wrongdoing.

"As Purdue Pharma has previously stated, the company is cooperating with investigative demands by various components of the U.S. Department of Justice in connection with criminal and civil investigations of the company," the Stamford, Connecticut-based drugmaker said in a statement.

Read more: https://www.msn.com/en-us/news/us/exclusive-oxycontin-maker-purdue-is-pharma-co-x-in-us-opioid-kickback-probe-sources/ar-BBZpZdM?li=BBnb7Kz

4 replies, 875 views

Reply to this thread

Back to top Alert abuse

Always highlight: 10 newest replies | Replies posted after I mark a forum
Replies to this discussion thread
Arrow 4 replies Author Time Post
Reply EXCLUSIVE-OxyContin maker Purdue is 'Pharma Co X' in U.S. opioid kickback probe -sources (Original post)
Yo_Mama_Been_Loggin Jan 28 OP
Hekate Jan 28 #1
DanieRains Jan 29 #2
nitpicker Jan 29 #3
ck4829 Jan 31 #4

Response to Yo_Mama_Been_Loggin (Original post)

Tue Jan 28, 2020, 09:47 PM

1. Goddam drug pushers & cold-blooded murderers. I want to see some very rich people convicted...

...and locked up for those crimes. The Sackler Gallery at The Smithsonian needs to expunge their name. Collecting fine art cannot wash out the stain of 10s of thousands of deaths.

Reply to this post

Back to top Alert abuse Link here Permalink

Response to Yo_Mama_Been_Loggin (Original post)

Wed Jan 29, 2020, 12:34 AM

2. Billionaires Are Above The Law - Number Of Corpses Matter None To "Justice" Today

Billionaires are above the law.

They just pay fines when they do crimes.

Reply to this post

Back to top Alert abuse Link here Permalink

Response to Yo_Mama_Been_Loggin (Original post)

Wed Jan 29, 2020, 04:23 AM

3. From the related DoJ PR


Department of Justice
Office of Public Affairs

Monday, January 27, 2020

Electronic Health Records Vendor to Pay $145 Million to Resolve Criminal and Civil Investigations

Practice Fusion Inc. Admits to Kickback Scheme Aimed at Increasing Opioid Prescriptions

Practice Fusion Inc. (Practice Fusion), a San Francisco-based health information technology developer, will pay $145 million to resolve criminal and civil investigations relating to its electronic health records (EHR) software, the Department of Justice announced today.

As part of the criminal resolution, Practice Fusion admits that it solicited and received kickbacks from a major opioid company in exchange for utilizing its EHR software to influence physician prescribing of opioid pain medications. Practice Fusion has executed a deferred prosecution agreement and agreed to pay over $26 million in criminal fines and forfeiture. In separate civil settlements, Practice Fusion has agreed to pay a total of approximately $118.6 million to the federal government and states to resolve allegations that it accepted kickbacks from the opioid company and other pharmaceutical companies and also caused its users to submit false claims for federal incentive payments by misrepresenting the capabilities of its EHR software.

The resolution announced today addresses allegations that Practice Fusion extracted unlawful kickbacks from pharmaceutical companies in exchange for implementing clinical decision support (CDS) alerts in its EHR software designed to increase prescriptions for their drug products. Specifically, in exchange for “sponsorship” payments from pharmaceutical companies, Practice Fusion allowed the companies to influence the development and implementation of the CDS alerts in ways aimed at increasing sales of the companies’ products. Practice Fusion allegedly permitted pharmaceutical companies to participate in designing the CDS alert, including selecting the guidelines used to develop the alerts, setting the criteria that would determine when a healthcare provider received an alert, and in some cases, even drafting the language used in the alert itself. The CDS alerts that Practice Fusion agreed to implement did not always reflect accepted medical standards. In discussions with pharmaceutical companies, Practice Fusion touted the anticipated financial benefit to the pharmaceutical companies from increased sales of pharmaceutical products that would result from the CDS alerts. Between 2014 and 2019, health care providers using Practice Fusion’s EHR software wrote numerous prescriptions after receiving CDS alerts that pharmaceutical companies participated in designing.

Practice Fusion executed a deferred prosecution agreement with the U.S. Attorney’s Office for the District of Vermont based on its solicitation and receipt of kickbacks from a major opioid company to arrange for an increase in prescriptions of extended release opioids by healthcare providers who used Practice Fusion’s EHR software. As detailed in the criminal Information made public today, Practice Fusion solicited a payment of nearly $1 million from the opioid company to create a CDS alert that would cause doctors to prescribe more extended release opioids. That payment was financed by the opioid company’s marketing department, and the CDS was designed with input from the marketing department. Practice Fusion and the opioid company entered the CDS sponsorship because they believed that the CDS would influence doctors’ prescriptions of extended release opioids. In marketing the “pain” CDS alert, Practice Fusion touted that it would result in a favorable return on investment for the opioid company based on doctors prescribing more opioids.


The civil settlement with the United States resolves Practice Fusion’s civil liability arising from the submission of false claims to federal healthcare programs tainted by the kickback arrangement between Practice Fusion and the opioid company. It also resolves allegations of kickbacks relating to thirteen other CDS arrangements where Practice Fusion agreed with pharmaceutical companies to implement CDS alerts intended to increase sales of their products. The $118.6 million settlement amount includes approximately $113.4 million to the federal government and up to $5.2 million to states that opt to participate in separate state agreements.

Reply to this post

Back to top Alert abuse Link here Permalink

Response to Yo_Mama_Been_Loggin (Original post)

Fri Jan 31, 2020, 08:53 PM

4. K&R

Reply to this post

Back to top Alert abuse Link here Permalink

Reply to this thread